| Continuous Use Celecoxib 200 mg qd | Intermittent Use Celecoxib 200 mg qd | |||
|---|---|---|---|---|
| BMI <30 kg/m2 n=209 | BMI ≥30 kg/m2 n=222 | BMI <30 kg/m2 n=205 | BMI ≥30 kg/m2 n=222 | |
| Female, n (%) | 145 (69.4) | 172 (77.5) | 149 (72.7) | 154 (69.4) |
| Age, years, mean (SD) | 59.2 (10.2) | 57.8 (9.8) | 58.9 (10.3) | 58.6 (9.0) |
| Race, white, n (%) | 156 (74.6) | 182 (82.0) | 151 (73.7) | 182 (82.0) |
| BMI, mean (SD) | 25.8 (2.6) | 34.9 (4.6) | 25.7 (2.6) | 35.0 (4.4) |
| Duration of OA, years, mean (SD) | 6.1 (6.3) | 6.5 (6.5) | 6.6 (6.8) | 7.0 (6.8) |
| Total WOMAC score, mean (SD) | 24.3 (14.0) | 26.2 (14.1) | 26.0 (14.8) | 26.5 (13.3) |
| WOMAC Subscale Scores, Mean (SD) | ||||
| Pain | 4.8 (3.0) | 5.0 (2.9) | 5.2 (3.1) | 5.0 (2.9) |
| Stiffness | 2.2 (1.4) | 2.4 (1.4) | 2.3 (1.4) | 2.5 (1.2) |
| Physical function | 17.3 (10.3) | 18.8 (10.5) | 18.4 (10.9) | 19.1 (9.9) |